Literature DB >> 24932534

Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Hebist Berhane1, Ashwin Shinde, Ronny Kalash, Karen Xu, Michael W Epperly, Julie Goff, Darcy Franicola, Xichen Zhang, Tracy Dixon, Donna Shields, Hong Wang, Peter Wipf, Song Li, Xiang Gao, Joel S Greenberger.   

Abstract

The altered DNA damage response pathway in patients with Fanconi anemia (FA) may increase the toxicity of clinical radiotherapy. We quantitated oral cavity mucositis in irradiated Fanconi anemia Fancd2(-/-) mice, comparing this to Fancd2(+/-) and Fancd2(+/+) mice, and we measured distant bone marrow suppression and quantitated the effect of the intraoral radioprotector GS-nitroxide, JP4-039 in F15 emulsion. We found that FA mice were more susceptible to radiation injury and that protection from radiation injury by JP4-039/F15 was observed at all radiation doses. Adult 10-12-week-old mice, of FVB/N background Fancd2(-/-), Fancd2(+/-) and Fancd2(+/+) were head and neck irradiated with 24, 26, 28 or 30 Gy (large fraction sizes typical of stereotactic radiosurgery treatments) and subgroups received intraoral JP4-039 (0.4 mg/mouse in 100 μL F15 liposome emulsion) preirradiation. On day 2 or 5 postirradiation, mice were sacrificed, tongue tissue and femur marrow were excised for quantitation of radiation-induced stress response, inflammatory and antioxidant gene transcripts, histopathology and assay for femur marrow colony-forming hematopoietic progenitor cells. Fancd2(-/-) mice had a significantly higher percentage of oral mucosal ulceration at day 5 after 26 Gy irradiation (59.4 ± 8.2%) compared to control Fancd2(+/+) mice (21.7 ± 2.9%, P = 0.0063). After 24 Gy irradiation, Fancd2(-/-) mice had a higher oral cavity percentage of tongue ulceration compared to Fancd2(+/+) mice irradiated with higher doses of 26 Gy (P = 0.0123). Baseline and postirradiation oral cavity gene transcripts were altered in Fancd2(-/-) mice compared to Fancd2(+/+) controls. Fancd2(-/-) mice had decreased baseline femur marrow CFU-GM, BFUe and CFU-GEMM, which further decreased after 24 or 26 Gy head and neck irradiation. These changes were not seen in head- and neck-irradiated Fancd2(+/+) mice. In radiosensitive Fancd2(-/-) mice, biomarkers of both local oral cavity and distant marrow radiation toxicity were ameliorated by intraoral JP4-039/F15. We propose that Fancd2(-/-) mice are a valuable radiosensitive animal model system, which can be used to evaluate potential radioprotective agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24932534      PMCID: PMC4101533          DOI: 10.1667/RR13633.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  34 in total

Review 1.  Fanconi anemia.

Authors:  Jean Soulier
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  GS-nitroxide (JP4-039)-mediated radioprotection of human Fanconi anemia cell lines.

Authors:  Mark E Bernard; Hyun Kim; Hebist Berhane; Michael W Epperly; Darcy Franicola; Xichen Zhang; Frank Houghton; Donna Shields; Hong Wang; Christopher J Bakkenist; Marie-Celine Frantz; Erin M Forbeck; Julie P Goff; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2011-09-22       Impact factor: 2.841

Review 3.  The Fanconi anemia pathway and DNA interstrand cross-link repair.

Authors:  Xiaoyu Su; Jun Huang
Journal:  Protein Cell       Date:  2011-09-23       Impact factor: 14.870

4.  Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.

Authors:  Hebist Berhane; Michael W Epperly; Julie Goff; Ronny Kalash; Shaonan Cao; Darcy Franicola; Xichen Zhang; Donna Shields; Frank Houghton; Hong Wang; Peter Wipf; Kalindi Parmar; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

5.  Regulation of the Fanconi anemia pathway by a SUMO-like delivery network.

Authors:  Kailin Yang; George-Lucian Moldovan; Patrizia Vinciguerra; Junko Murai; Shunichi Takeda; Alan D D'Andrea
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

6.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway.

Authors:  I Garcia-Higuera; T Taniguchi; S Ganesan; M S Meyn; C Timmers; J Hejna; M Grompe; A D D'Andrea
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

Review 7.  Fanconi's anemia and malignancies.

Authors:  B P Alter
Journal:  Am J Hematol       Date:  1996-10       Impact factor: 10.047

8.  Numerical chromosomal changes and risk of development of myelodysplastic syndrome--acute myeloid leukemia in patients with Fanconi anemia.

Authors:  Parinda A Mehta; Richard E Harris; Stella M Davies; Mi-Ok Kim; Robin Mueller; Beatrice Lampkin; Jun Mo; Kasiani Myers; Teresa A Smolarek
Journal:  Cancer Genet Cytogenet       Date:  2010-12

Review 9.  Why does the bone marrow fail in Fanconi anemia?

Authors:  Juan I Garaycoechea; K J Patel
Journal:  Blood       Date:  2013-11-07       Impact factor: 22.113

10.  The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair.

Authors:  Puck Knipscheer; Markus Räschle; Agata Smogorzewska; Milica Enoiu; The Vinh Ho; Orlando D Schärer; Stephen J Elledge; Johannes C Walter
Journal:  Science       Date:  2009-11-12       Impact factor: 47.728

View more
  19 in total

1.  FANCD2 protects against bone marrow injury from ferroptosis.

Authors:  Xinxin Song; Yangchun Xie; Rui Kang; Wen Hou; Xiaofang Sun; Michael W Epperly; Joel S Greenberger; Daolin Tang
Journal:  Biochem Biophys Res Commun       Date:  2016-10-20       Impact factor: 3.575

2.  Evaluation of Different Formulations and Routes for the Delivery of the Ionizing Radiation Mitigator GS-Nitroxide (JP4-039).

Authors:  Michael W Epperly; Peter Wipf; Renee Fisher; Darcy Franicola; Jan Beumer; Song Li; Rhonda M Brand; Louis D Falo; Geza Erdos; Joel S Greenberger
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Anti-Ferroptosis Drug Enhances Total-Body Irradiation Mitigation by Drugs that Block Apoptosis and Necroptosis.

Authors:  Stephanie Thermozier; Wen Hou; Xichen Zhang; Donna Shields; Renee Fisher; Hulya Bayir; Valerian Kagan; Jian Yu; Bing Liu; Ivet Bahar; Michael W Epperly; Peter Wipf; Hong Wang; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2020-03-05       Impact factor: 2.841

4.  Effectiveness of Analogs of the GS-Nitroxide, JP4-039, as Total Body Irradiation Mitigators.

Authors:  Michael W Epperly; Joshua R Sacher; Tanja Krainz; Xiaolin Zhang; Peter Wipf; Mary Liang; Renee Fisher; Song Li; Hong Wang; Joel S Greenberger
Journal:  In Vivo       Date:  2017-01-02       Impact factor: 2.155

5.  Improved Total-Body Irradiation Survival by Delivery of Two Radiation Mitigators that Target Distinct Cell Death Pathways.

Authors:  Justin Steinman; Michael Epperly; Wen Hou; John Willis; Hong Wang; Renee Fisher; Bing Liu; Ivet Bahar; Travis McCaw; Valerian Kagan; Hulya Bayir; Jian Yu; Peter Wipf; Song Li; M Saiful Huq; Joel S Greenberger
Journal:  Radiat Res       Date:  2017-11-15       Impact factor: 2.841

6.  Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.

Authors:  Ashwin Shinde; Hebist Berhane; Byung Han Rhieu; Ronny Kalash; Karen Xu; Julie Goff; Michael W Epperly; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Kalindi Parmar; Eva Guinan; Valerian Kagan; Vladimir Tyurin; Robert L Ferris; Xiaolan Zhang; Song Li; Joel S Greenberger
Journal:  Radiat Res       Date:  2016-01-20       Impact factor: 2.841

Review 7.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

8.  Induction of TGF-β by Irradiation or Chemotherapy in Fanconi Anemia (FA) Mouse Bone Marrow Is Modulated by Small Molecule Radiation Mitigators JP4-039 and MMS350.

Authors:  Michael W Epperly; Byung-Han Rhieu; Darcy Franicola; Tracy Dixon; Shaonan Cao; Xichen Zhang; Donna Shields; Hong Wang; Peter Wipf; Joel S Greenberger
Journal:  In Vivo       Date:  2017 Mar-Apr       Impact factor: 2.155

9.  Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca-/- and Fancg-/- Mice by Intraoral Administration of GS-Nitroxide (JP4-039).

Authors:  John Willis; Michael W Epperly; Renee Fisher; Xichen Zhang; Donna Shields; Wen Hou; Hong Wang; Song Li; Peter Wipf; Kalindi Parmar; Eva Guinan; Justin Steinman; Joel S Greenberger
Journal:  Radiat Res       Date:  2018-03-27       Impact factor: 2.841

10.  Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.

Authors:  Michael W Epperly; Renee Fisher; Xichen Zhang; Wen Hou; Donna Shields; Peter Wipf; Hong Wang; Stephanie Thermozier; Joel S Greenberger
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.